#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins
MADRID — In a testament to clinicians’ interest in Merck and Moderna’s personalized cancer vaccine data at this year’s European Society for Medical Oncology conference, the presidential symposium, which can seat thousands of people, was full ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.